secwatch.observer — SEC 8-K summary
======================================

Issuer:     SYNOPSYS INC (SNPS)
CIK:        0000883241
Form:       8-K
Filed at:   2022-05-25T23:59:59+00:00
Accession:  0001193125-22-159178
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Synopsys appoints Luis Borgen and Marc Casper to board, expands from 8 to 10 directors
--------------------------------------------------------------------------------

- Board expanded from 8 to 10 members; Borgen and Casper appointed as independent directors effective immediately.
- Luis Borgen most recently CFO of athenahealth; Marc Casper is chairman, president, and CEO of Thermo Fisher Scientific.
- Each new director receives $125,000 annual cash retainer and initial equity grants (stock option $350k FMV, restricted stock $175k prorated).
- Board expects to assign each to board committees at a later date; standard indemnification agreements entered.
- CEO Aart de Geus cites their operational experience to help scale Synopsys to $5 billion and beyond.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883241/000119312522159178/0001193125-22-159178-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883241/000119312522159178/d356707d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-159178

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer